Background
==========

The isolation and gene expression profiling of embryonic circulating nRBCs would be of great interest to developmental biologists and clinicians alike \[[@B1]\], yet due to limited sample size available from traditionally used model organisms, harvesting a sufficiently large pool of embryonic nRBCs for transcriptome-wide analysis has been difficult. Alternative approaches using perinatal blood have already yielded significant insights \[[@B2]\]. The chick embryo is both large in size and contains a circulatory network of a complexity equal to that of mammals. Herein, we describe the isolation and gene expression profiling of circulating cells during the transition phase of hematopoiesis from primitive or yolk sac associated, to definitive hematopoiesis, at embryonic days 4 and 6. It is during this time that hematopoiesis occurs transiently in the peri-aortic region in the chick embryo (referred to in mammals as the aorta-gonad-mesonephros or AGM), before transitioning to the bone marrow \[[@B3],[@B4]\].

Results and Discussion
======================

Chick blood was isolated from embryos at E4 and E6, using micro-capillaries inserted directly into the heart. Density gradient centrifugation was then employed to isolate the heavier RBCs from a lighter nRBC population from total embryonic blood. Cells within the two populations were analyzed directly by FACS, and by the classical hematological stains Giemsa, benzidine, and Periodic-acid Schiff (PAS). Using these techniques, we were able to confirm that two distinct, viable populations; one highly enriched in RBCs, and another population highly depleted of RBCs (nRBCs) had been isolated (Fig. [1](#F1){ref-type="fig"}).

![Characterization of RBC and nRBC cellular fractions. (A) Appearance of cell populations following density gradient centrifugation, along with control density marker beads. (B) FACSAria (BD Biosciences) profile of RBC and nRBCs after propidium iodide labeling of dead cells. The number of small (FSC), agranular (SSC) cells is greater in the nRBC fraction; \>90% of cells from both populations are viable based on propidium iodide exclusion and Trypan blue exclusion (not shown). (C) nRBCs have a large nuclear volume, and smaller size (Giemsa), are benzidine negative and PAS positive. Bar = 20 μm.](1471-213X-8-21-1){#F1}

Further characterization of these populations by RT-PCR demonstrated that nRBCs had high expression levels of the hematopoietic stem cell antigen CD34, whereas the RBC population lacked expression of this gene (Fig. [2B,C](#F2){ref-type="fig"}). After these preliminary findings had given validity to our technique, gene expression profiling was performed using Affymetrix Gene Expression Arrays. For RNA isolation, handling time was kept to a minimum and cell collection to lysis for RNA extraction was performed in less than one hour. Consequently, cells were not subjected to long incubation periods on ice, or in serum containing medium, which can alter gene expression, as is the case for other commonly used in techniques such as FACS sorting. RNA from both E4 and E6 RBC and nRBC samples were analyzed by duplicate Affymetrix gene chips, from separate, pooled biological samples (30--100 embryos/array). Comparisons between RBC and nRBC populations were made, and the expression levels of candidate genes were confirmed by PCR (Fig. [2A--C](#F2){ref-type="fig"}). The resulting array data has been deposited into NCBI Gene Expression Omnibus (GEO) under the accession number GSE9884. We considered genes to be significantly enriched in the nRBC population by the following two criteria: 1) that they are expressed at higher levels in the nRBC than the RBC population by the SAM algorithm; 2) that they are not expressed at high levels in the heart (Fig. [3](#F3){ref-type="fig"}).

![Array analysis and RT-PCR verification. (A) Heat map generated by TM4 SAM analysis with genes verified by PCR highlighted. (B) Semi-quantitative PCR analysis of candidate genes from array data and control GAPDH and 18S, and embryonic hemoglobin transcripts (pan-globin) in cDNAs from both E4 and E6 RBC and nRBC fractions. (C) QPCR data. All genes tested had significantly higher expression in nRBCs by Student\'s T-test (except for CD51). Hemoglobins are the only genes with significantly higher expression in RBCs. E4 data: left-hand bars, E6 data: right-hand bars.](1471-213X-8-21-2){#F2}

![Representative array expression profiles generated by eXintegrator analysis. Example candidate genes kept from TM4 analysis (left) display an observable gradient of low expression in RBC samples and high expression in nRBC samples, and low-to-moderate expression in heart. Example candidate genes discarded from TM4 analysis (right) following examination by eXintegrator display high expression in negative control sample (heart).](1471-213X-8-21-3){#F3}

Hematopoietic Stem Cell (HSC) Associated Genes are Upregulated in nRBCs
-----------------------------------------------------------------------

Many genes known to be associated with HSCs were found to be preferentially expressed in nRBCs, such as the HSC membrane receptor glycoprotein (GP) CD45 (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}) \[[@B5]\]. Moreover, transcription factors Ets-1 \[[@B6]\], HEX \[[@B7]\], KLF2 \[[@B8]\] and PU.1 \[[@B9]\], known to be essential for primitive and definitive hematopoiesis, were detected specifically in the nRBC population; as were the signaling molecules BLNK \[[@B6]\], FYN \[[@B10]\], RGS18 \[[@B11]\], Rac2 \[[@B12]\], LYN and SYK \[[@B13]\], VAV3 \[[@B14]\] and the ion channel Slo1 \[[@B15]\]. Additionally, the expression of many integrins, which are known to play an important role in the adhesion and homing of HSCs, were detected in nRBCs. A significant overlapping integrin repertoire was observed between nRBCs and a previous study on adipose derived stromal CD31+ HSCs and includes: CD18 (ITGB2), CD49B (ITGA2), CD49F (ITGA6), CD51 (ITGAV), CD61 (ITGB3/GPIIIa), and the non-integrin cell adhesion molecule CD166 (ALCAM) \[[@B16]\]. In addition to integrins, previous work has established an important role for GPs (e.g. CD34, CD45, CD61) in the adhesion and possibly homing of HSCs, and has demonstrated the expression of the GP receptor CD62L, and the GP Cystatin-7 on HSCs \[[@B17],[@B18]\]. Finally, cell-cell communication required during later differentiation of HSCs in the stroma is known to be mediated by the gap junctional protein connexin 43 (Cx43), another gene detected in the nRBC population \[[@B19]\].

###### 

Genes significantly upregulated in nRBCs. Listed genes are ranked according to expression level in nRBCs shown as Log2 expression values. Genes highlighted in bold were verified by PCR.

  **Probe Set ID**           **Gene Name**                                                                    **nRBC**   **RBC**
  -------------------------- -------------------------------------------------------------------------------- ---------- ---------
  Gga.1039.1.S1_at           **CD61, Integrin Beta 3 (Platelet Glycoprotein IIIa)**                           7.53       0.81
  Gga.4472.3.S1_x\_at        Thymosin Beta 4 TOLL-Like Receptor 7 (TLR7)                                      7.5        2.35
  Gga.9122.1.S1_at           ETS-1 (p54)                                                                      7.31       -0.07
  Gga.15362.1.S1_at          **RGS18 Regulator of G-protein Signalling 18**                                   7.11       -3.73
  Gga.1187.2.S1_s\_at        PINCH-1 hypothetical                                                             7.07       4.02
  Gga.5362.1.S1_a\_at        **Elfin, PDZ and LIM Domain Protein 1 (PDLIM-1)**                                6.81       -0.18
  Gga.10042.1.S1_a\_at       **CD200 Receptor 1 (CD200R)**                                                    6.78       -1.78
  Gga.6387.1.S1_at           p21 Rac2                                                                         6.74       -1.68
  Gga.2876.1.S2_a\_at        VAV3                                                                             6.65       -1.71
  Gga.19950.1.S1_s\_at       Coagulation Factor XIII, A1 Polypeptide                                          6.49       -2.26
  Gga.3316.1.S1_s\_at        **HEX probox protein**                                                           6.44       1.91
  Gga.12960.1.S1_at          Phospholipase C Gamma 2 (PLCG2)                                                  6.29       -1.81
  Gga.4451.1.S1_at           Gelsolin                                                                         6.14       0.08
  Gga.9413.1.A1_at           Prostaglandin-Endoperoxide Synthase 1 (COX-1)                                    6.06       2.28
  Gga.6665.1.A1_at           Peptide Methionine Sulfoxide Reductase (MSRA)                                    5.98       -1.16
  Gga.514.1.S1_at            Coagulation Factor X Precursor Virus Activating Protease                         5.79       -1.51
  Gga.7018.1.S1_s\_at        Fgd3, FYVE, RhoGEF and PH domain containing 3                                    5.79       0.51
  GgaAffx.13009.1.S1_at      Tumor Necrosis Factor Alpha Induced Protein 8 (TNFAIP-8)                         5.52       1.71
  Gga.4772.1.S1_at           Connexin 43 (Cx43)                                                               5.46       -3.4
  Gga.11854.1.S1_at          Tetraspanin 6 (TSPAN6)                                                           5.44       0.48
  Gga.4350.1.S2_at           FYN Oncogene Related to SRC, FGR, YES                                            5.32       -0.29
  Gga.1193.1.S2_at           **CD45, Protein Tyrosine Phosphatase Receptor Type C**                           5.24       -1.89
  Gga.3828.1.S1_at           ZOV3, Embigin Homolog                                                            5.24       0.61
  Gga.16474.1.S1_at          Pleiotrophin (PTN) Osteoblast-Specific Factor 1 (OSF-1)                          5.16       -3.79
  GgaAffx.21842.1.S1_s\_at   Beta Defensin 7 (Gal 7)                                                          5.13       0.18
  Gga.11496.1.S1_at          CD62L, L-Selectin                                                                5.09       -1.48
  Gga.4225.1.S1_at           Leukocyte Cell-derived Chemotaxin 2 (LECT2)                                      4.89       0.24
  Gga.10034.1.S1_at          Similar to Plasminogen Activator Inhibitor (PAI)                                 4.85       -3.93
  Gga.2734.1.S2_at           CD166, Activated Leukocyte Cell Adhesion Molecule (ALCAM)                        4.67       -2.35
  Gga.13583.1.S1_at          **CD36, Thrombospondin Receptor (Platelet Glycoprotein IV)**                     4.66       -2.74
  Gga.2967.1.S2_at           CD49F, VLA6, Integrin Alpha 6                                                    4.47       -0.16
  Gga.19342.1.S1_at          Calcium-Activated Potassium Channel Subunit Alpha, Slowpoke (Slo1)               4.45       -3.99
  Gga.5758.1.S1_s\_at        LYN, Yamaguchi Sarcoma Viral Related Oncogene Homolog (vYES-1)                   4.45       -1.42
  GgaAffx.12646.1.S1_at      Spleen Tyrosine Kinase (SYK)                                                     4.42       -2.6
  Gga.3899.3.S1_a\_at        Platelet-Derived Growth Factor Alpha (PDGF-A)                                    4.38       -2.38
  Gga.4832.1.S1_at           Interferon Inducible Transmembrane Protein 3 (IITMP3, Fragilis)                  4.25       -0.06
  Gga.11657.1.S1_at          Thrombin Receptor, Coagulation Factor II Receptor                                4.02       -1.14
  Gga.11741.1.S1_a\_at       Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor)   3.98       -2.99
  Gga.15893.1.S1_at          **CD49B, Integrin Alpha 2 (Platelet Glycoprotein IIb)**                          3.94       -2.95
  GgaAffx.22186.2.S1_s\_at   Interleukin-1 Receptor Accessory Protein Precursor (IL1RAP)                      3.88       -1.26
  GgaAffx.13138.1.S1_at      Tumor Necrosis Factor (ligand) Superfamily Member 13b (TNFSF-13b)                3.75       -1.88
  GgaAffx.13210.1.S1_at      SRC Like Adaptor (SLAP)                                                          3.62       -4.21
  Gga.690.1.S1_at            LY64, MD-1                                                                       3.51       -0.47
  Gga.3738.1.S1_at           **B-cell Linker (BLNK)**                                                         3.46       -1.18
  Gga.4943.1.S1_at           Tumor Necrosis Factor Receptor Superfamily, Member 21                            3.32       -1.4
  Gga.5743.1.S1_at           LY96, MD-2                                                                       3.31       -3.02
  GgaAffx.20689.1.S1_at      Spleen Focus Forming Virus (SFFV) Proviral Integration Oncogene (SPI-1, PU.1)    3.29       -2.58
  Gga.815.1.S1_at            **CD51, Integrin Alpha V**                                                       3.02       -2.36
  GgaAffx.20858.1.S1_at      Cell Adhesion Molecule with Homology to L1CAM Precursor (CHL1)                   2.89       -2.24
  Gga.2039.1.S1_at           Heme Oxygenase (decycling) 1 (HMOX1)                                             2.88       -2.69
  GgaAffx.11713.1.S1_s\_at   Rho Guanine Nucleotide Exchange Factor 3 (GEF-3)                                 2.74       -1.8
  Gga.3070.1.S1_at           CD121A, Interleukin-1 Receptor Type I                                            2.65       -3.35
  Gga.1980.1.S1_s\_at        Thrombospondin 4 (THBS4)                                                         2.59       -2.6
  Gga.11824.1.S1_at          Cystatin F, Leukocystatin                                                        2.53       -3.57
  Gga.4507.1.S1_at           CD18, Integrin Beta 2                                                            2.27       -2.61
  GgaAffx.24377.2.S1_s\_at   Beta Parvin                                                                      2.22       -2.93
  Gga.7769.1.S1_at           Fgd5, FYVE, RhoGEF and PH Domain Containing 5                                    2.15       -2.87
  Gga.7528.1.S1_at           Kruppel-like Factor 2 (KLF-2)                                                    2.07       -1.91
  GgaAffx.1733.2.S1_s\_at    CD62P, Cell Adhesion Molecule LECAM3                                             1.37       -3.73

###### 

Genes significantly upregulated in nRBCs shown by gene categorization according to functional association. From left to right, genes with a known role in HSCs, myeloid cell lineage, lymphoid cell lineage, other types of non-hematopoietic cells (germ cells, neuronal or cardiac progenitors) or genes with no known role in development. Genes highlighted in bold were verified by PCR.

  ***HSC (22)***   ***Myeloid (17)***                ***Lymphoid (10)***   ***Germ Line (2)***
  ---------------- --------------------------------- --------------------- ---------------------
  **BLNK**         **CD36**                          β-Defensin            Fragilis
  CD18             **CD49B**                         CD121A                Zov3
  **CD45**         **Cd51**                          HMOX1                 
  **CD49B**        **CD61**                          LECT2                 ***Neural (2)***
  CD49F            CD62P                             MD1                   PTN
  **CD51**         **CD200R**                        MD2                   TSP4
  **CD61**         Coagulation Factor X              TLR7                  
  CD62L            Coagulation Factor XIII           TNFSF13b              ***Cardiac (2)***
  CD166            COX-1                             TNFSFR21              **Elfin**
  **CD200R**       Gelsolin                          SLAP                  PINCH1
  Cx43             PAI-1                                                   
  Cystatin F       PDGFA                                                   ***Unknown (8)***
  ETS-1            PLCG2                                                   β-PARVIN
  FYN              PU.1                                                    FGD3
  KLF2             Thrombin Receptor                                       FGD5
  LYN              Tissue Factor Pathway Inhibitor                         IL1RAP
  PU.1             **VAV3**                                                L1CAM
  Rac2                                                                     MSRA
  **RGS18**                                                                TNFAIP8
  Slo1                                                                     TSPAN6
  SYK                                                                      
  **VAV3**                                                                 

Myeloid Markers Expressed by nRBCs
----------------------------------

In addition to the expression of GPs on HSCs, expression of the platelet GP ligand CD62P (P-selectin), important for HSC adherence \[[@B20]\], and the myeloid GPs CD200R \[[@B21]\] and CD36 \[[@B22]\] were detected in the nRBC population. Other markers of the undifferentiated myeloid lineage including gelsolin \[[@B23]\] and PU.1 were both detected in nRBC fraction. Furthermore, many genes detected in nRBCs can be associated with platelet activation pathways such as, Coagulation Factors X and XIII, COX-1, PAI, PDGF, PLCG2, Tissue Factor Pathway Inhibitor, Thrombin Receptor, and VAV3 \[[@B24]-[@B27]\].

Lymphoid Markers Expressed by nRBCs
-----------------------------------

Our expression profiling of nRBCs reveals not only the known potential of early circulating embryonic cells towards myeloid and erythroid lineages, but also that of the lymphoid lineage. The expression of leukocyte specific genes which are part of the innate immune system such as the lymphocyte antigens LY64 (MD1) and LY96 (MD2), Toll-like receptor 7 (TLR7) \[[@B28]\] as well as Interleukin 1 Receptor (CD121A) \[[@B29]\], β-Defensin \[[@B28]\], members of the TNF signaling pathway, TNFSF13b (BAFF) and TNFSFR21 (DR6), which can mediate the innate immune response \[[@B30]\], and LECT2, which is involved in neutrophil chemotaxis \[[@B31]\], demonstrate that a lymphoid differentiation potential is already present at the peri-aortic stage, a finding which has been reported previously for similarly staged AGM derived cells in mice \[[@B32]\]. The only gene expressed in nRBCs which has a role in acquired immunity appears to be the Src-like adaptor molecule, SLAP, whose function is to repress surface IgM expression on B-cells \[[@B33]\]. Interestingly, the heme oxygenase-1 (HMOX1) an essential enzyme in heme catabolism, was the only true erythroid associated gene detected in the nRBCs. However, the expression of HMOX1 has been reported in a variety of primitive and definitive white blood cell types as well, although it does not appear to be essential for their development \[[@B34]\].

Germ Cell, Neural, and Cardiac Markers Expressed by nRBCs
---------------------------------------------------------

Additional categories of genes that were observed in nRBCs include: Fragilis and Zov3 (associated with germ cells) \[[@B35],[@B36]\], and Pleiotrophin (PTN) and Thrombospondin-4 (THSB4) (found in neuronal stem cells and progenitors) \[[@B37],[@B38]\]. Moreover, despite being negatively screened against genes upregulated in the heart (Fig. [3](#F3){ref-type="fig"}), Elfin, and PINCH-1, which mark early cardiac cells \[[@B39],[@B40]\], were detected in circulating nRBCs.

Additional Genes Expressed by nRBCs
-----------------------------------

Finally, a list of genes with unknown functions has emerged from this screen. Although the Interleukin-1 Receptor Associated Protein (IL1RAP) and TNF-alpha Interacting Protein 8 (TNFAIP8) are likely to be involved in the innate immune response, the other 6 genes remain developmentally uncharacterized, and may provide insight into the function and differentiation of HSCs (Table [2](#T2){ref-type="table"}). Interestingly, the Peptide Methionine Sulfoxide Reductase gene (MSRA), which was expressed in nRBCs, may help to protect progenitor cells against oxidative stress \[[@B41]\], although conclusive proof to this end remains to be demonstrated.

Further Expression Validation: ISH, IHC and FACS
------------------------------------------------

Following our expression profiling at the in vitro level, we next verified our expression data for certain interesting candidate nRBC expressed genes, for which QPCR had been performed, by wholemount is situ hybridization (ISH) and immunostaining (IHC) of the yolk sac. At E4 and E6, the time points analyzed, the yolk sac is highly vascularized and provides a receptacle for circulating cells transiting to and from the embryonic and extraembryonic regions. Reproducible labeling of rare positive circulating cells was observed for CD61, CD200R, and HEX, whereas infrequent clusters of positive cells were found to express RGS18 by ISH (Fig. [4](#F4){ref-type="fig"}). Furthermore, HEX expression was observed in large numbers of mesenchymal cells neighboring blood vessels either containing, or devoid of HEX positive circulating cells. CD200R occasionally labeled cells with an endothelial morphology. IHC for the CD51/CD61 heterodimer or vitronectin receptor (alpha3betaV integrin) revealed expression in rare circulating small rounded cells which were either clumped and associated with the endothelium, or singular. FACS analysis using this antibody demonstrated that 4% of nRBCs are positive for this antigen, whereas RBC staining was negligible (Fig. [5](#F5){ref-type="fig"}). ρ-globin, which is still prominently expressed in both E4 and E6 RBCs \[[@B42]\], was used as a positive control for yolk sac ISH (Fig. [4](#F4){ref-type="fig"}). ρ expression was observed in the majority of circulating cells, but was negative in certain infrequent cells presenting non-RBC morphology.

![In situ hybridization and histological analyses. From the 12 candidate genes used for QPCR 6 probes were generated that gave some positive signal at earlier embryonic stages; 4 of these stained small numbers of cells in the yolk sac, with the remaining 2 no positive cells were detectable. Embryonic ρ-globin is expressed in the vast majority of circulating cells but is observed to be negative in some rare cells (arrows), whereas CD200R, CD61, HEX, RGS18 and the vitronectin receptor (CD51/61) are expressed in scattered circulating (arrows) and attached cells (arrowheads) throughout the yolk sac vasculature. Red contours outline the vascular lumen. Left and right panels indicate distinct staining of single cells with the indicated probe or antibody. Bars = 20 μm.](1471-213X-8-21-4){#F4}

![FACS profile of fractionated blood stained with PE-conjugated vitronectin receptor antibody 23C6. The number of positive cells is significantly increased in nRBCs.](1471-213X-8-21-5){#F5}

Conclusion
==========

In summary, gene expression profiling of nRBCs in the chick embryo has revealed the expression of a set of genes indicative of a wide range of hematopoietic stem cells and progenitors primarily of either the erythroid or myeloid lineages present in early circulation. It has indeed been postulated that cells with an \"erythromyeloid\" potential constitute the first subset of HSCs with potential for liver engraftment and eventual long-term hematopoiesis in the bone marrow \[[@B43]\]. Lastly, the identification of several previously undescribed genes may prompt closer examination of their functions in chick and other model organisms. We, however, do not observe a prominent difference in expression profiles between E4 nRBCs and E6 nRBCs, during which period the second wave of HSC generation is actively taking place in the peri-aortic region, transiting from the initial appearance of intra-aortic clusters at about E4 to the formation of para-aortic foci at E6 \[[@B4]\]. It is therefore unclear whether the nRBCs we detect in E4-6 circulation, with the profiles of hematopoietic cells and progenitors, represent those from yolk sac or peri-aortic cells.

Methods
=======

Blood Isolation
---------------

Blood was collected from the embryonic ventricles using fine glass microcapillaries. Cells were washed in PBS-EDTA, centrifuged at 1500 g, and separated on a RediGrad:NaCl (9:2.5) density gradient (Amersham) by centrifugation for 20 minutes at 10,000 g. Upper nRBC and lower RBC populations were collected by pipette and placed in RNA lysis buffer or assayed using chemical stains or FACS.

Benzidine Staining
------------------

RBC and nRBC populations were smeared onto glass slides and fixed in 2.5% gluteraldehyde for 1 hr. A 0.1% Benzidine staining solution was then applied (0.001 g/ml benzidine; 0.0068 g/ml imidazole; 0.05 M Tris-HCl, pH7.6; 0.3% H~2~O~2~) for 1 hr at 37°C. Slides were then briefly washed in PBS, dehydrated in ethanol, mounted and photographed.

RNA Isolation and RT-PCR
------------------------

Cells were lysed using QIAshredder spin columns and total RNA was extracted using the RNeasy total RNA extraction kit (Qiagen). Equal amounts of total RNA from each sample were converted to first-strand cDNA in parallel with the Superscript III reverse transcriptase synthesis system (Invitrogen). Real-time QPCR was performed using Quantitect SYBR PCR master mix (Qiagen) in a 7900 HT Fast Real-Time PCR System (Applied Biosystems). All PCRs were performed in duplicate with at least 2 biological samples at an annealing temperature of 60°C, using between 30 and 45 amplification cycles. Analysis of the melting curve excluded the amplification of unspecific products. In each QPCR run, a standard curve was generated using duplicate 6-log spanning serial dilutions. PCR products for standard curves were column-purified, measured for DNA concentration, sized by agarose gel electrophoresis, sequenced, aliquoted and stored at -80°C for a maximum of 2 months. Standard curves were calculated by SDS software, and test samples were fitted to the generated curve (Applied Biosystems). Primer sequences are available in Table [3](#T3){ref-type="table"}.

###### 

Primer sequences used for PCR and in situ probe generation

  ------------------------------ -----------------------------
  **[PCR PRIMERS]{.ul}**         
  18S rRNA FORWARD               CGAAAGCATTTGCCAAGAAT
  18S rRNA REVERSE               GAGTCGGCATCGTTTATGGT
  BLNK FORWARD                   GAAATCGCCTTCATCCAAAA
  BLNK REVERSE                   ACCAAGGAGGTATGCTGGTG
  CD34 FORWARD                   GCAACAACACTGCTCAGCTC
  CD34 REVERSE                   TTGCTGACACCACCAGATGT
  CD36 FORWARD                   AAGGAAAGACCCTTGCCAAT
  CD36 REVERSE                   ATTGCTGCAGTTTCCATTCC
  CD45 FORWARD                   GCCAAGAGGAGCCATAATCA
  CD45 REVERSE                   ATCCTGGGTCTCCTGGAATC
  CD49B FORWARD                  AAAAGAAACGTTGCAAATGAAAT
  CD49B REVERSE                  GTTTCTGACTTCTCTGCTGCAA
  CD51 FORWARD                   CATTGAAGGAGACGTGCAAA
  CD51 REVERSE                   AGTTTGGGTCCAAAGTCGTG
  CD61 FORWARD                   TTAACAACCCCTTGGCTGTC
  CD61 REVERSE                   CCACCGAGGTAAGGATGAGA
  CD200R FORWARD                 TGGTGACTGTCCTTGTGGAA
  CD200R REVERSE                 GACACAGTGGAGGTGGAACC
  Elfin FORWARD                  AGCTGCAATAGCCAACCTGT
  Elfin REVERSE                  GCTCATCTGCACAGCTCTTG
  GAPDH FORWARD                  TGGGTGTCAACCATGAGAAA
  GAPDH REVERSE                  CATCCACCGTCTTCTGTGTG
  HEX FORWARD                    CCCAGATTTCCCATTTCAGA
  HEX REVERSE                    TACACGAGCAGAGAGGGACA
  Pan globin FORWARD             ACCGCCAAGTACCGTTAAGA
  Pan globin REVERSE             TTCATCTCATTTGGCTGCTC
  RGS18 FORWARD                  AAATAAGTGGCAAGCAAAGTTGA
  RGS18 REVERSE                  CAGCAATAAGTTGCCTGGTTG
  Vav3 FORWARD                   TCCGCTTGCAAACAATTACA
  Vav3 REVERSE                   CTCAGGGTGATGGGGAGATA
                                 
  **[ISH PROBE PRIMERS]{.ul}**   
  CD61 FORWARD                   CACCGTGTGTGATGAGAAAA
  CD61 REVERSE                   ACAGGTTTGATGGTGAAGGA
  CD200 FORWARD                  TGGCTCTGTACTGCGATGAC
  CD200 REVERSE                  GAACAGCAAGGGAAAACCAA
  CD200 T7 REVERSE               TAATACGACTCACTATAGGGAACAGC
  HEX FORWARD                    GACTACACGCACGCACTGATC
  HEX REVERSE                    CAAACTGCTATGTACACGAGCAG
  RGS18 FORWARD                  CTTCCCACTACCTGCTCTGC
  RGS18 REVERSE                  GGACCGTGATCGTCTCCTAA
  RGS18 T7 REVERSE               TAATACGACTCACTATAGGGGACCGTG
  ------------------------------ -----------------------------

Affymetrix Array Data Analysis
------------------------------

Amplification of 100 ng of RNA using the Two-Cycle cDNA Synthesis Kit and IVT Labeling Kit (Affymetrix) and subsequent hybridization and scanning was carried out by the Functional Genomics Unit (RIKEN CDB). Pivot raw data files from duplicate microarray experiments were analyzed using the TIGR MultiExperiment Viewer 4.0 (TM4) software package. Briefly, data was log2 transformed, subjected to quantile normalization and analyzed by SAM (Significance Analysis for Microarrays), using 100 random data permutations, and a delta value of 2.5 (p value 0.0018) (Fig. [6](#F6){ref-type="fig"}). This cutoff was used to minimize false positives, but as a consequence created potential false negatives. A number of previously described hematopoietic markers such as RUNX-1 (Affy ID: Gga.1019.1.S1_at) and cKIT (Affy ID: Gga.606.1.S1_at) were found using a delta value of 0.9 (p value 0.05), but were excluded from our analysis. Hierarchical clustering of significant data points was then carried out by Co-variance algorithm \[[@B44]\]. All significant data points generated by SAM analysis were double checked manually using the eXintegrator software package \[[@B45],[@B46]\] against negative control E6 embryonic heart array data, which was not performed in duplicate. Data points with high expression in heart were eliminated (Fig. [3](#F3){ref-type="fig"}). Quality control of microarray data, which was well within an acceptable range, was performed using the Bioconductor Affy array analysis suite \[[@B47]\].

![Statistical analyses of the complexity of RBC and nRBC transcriptomes. (A) Summary of present (P) calls for all arrays used in this study as a percentage of all calls (either present, P; absent, A; or missing, M). nRBCs have 10% more P calls than RBCs. Nevertheless, 1/4 of the RBC transcriptome is scored as present. (B) Graphical representation of SAM analysis showing significantly different genes between nRBCs and RBCs in red, which were examined in this study. (C) Grouped T-test between RBCs and nRBCs shows that for a confidence level of 95%, 98% of the hybridization values for probe sets between these two groups are not significantly different.](1471-213X-8-21-6){#F6}

Wholemount ISH and IHC
----------------------

Yolk sacs from E4 and E6 embryos were collected and fixed in 4% paraformaldehyde, and cut into small pieces to allow greater probe and antibody diffusion. For ISH, samples were processed as described previously \[[@B48]\]. Probes for CD200R and RGS18 were generated by 2 round PCR using primers given in Table [3](#T3){ref-type="table"}. Probes for CD61, ρ-globin and HEX were cloned into pGEM-T vector. The probe for embryonic ρ-globin has been described previously \[[@B42]\]. Probe templates were verified by sequencing. RNA probes were generated by either T7 or Sp6 in vitro transcription, and verified by agarose gel electrophoresis. For IHC, all solutions were TBST based. Tissue was blocked for 1 hr (5% sheep serum 1 mg/ml BSA), incubated with mouse anti-human vitronectin antibody, clone 23C6, with known cross reactivity in chicken \[[@B49]\] (BioLegend) at a dilution of 1:40 overnight at 4°C, washed once and blocked for endogenous peroxidase activity, washed again 3×, incubated for 1 hr in secondary HRP conjugated anti-mouse, washed 3×, and developed using DAB solution (Sigma-Aldrich). All tissues were embedded in wax and sectioned to 9 μm on a MICROM HM325 Microtome. IHC samples were counterstained with hematoxylin.

FACS
----

Fluorescent Assisted Cell Sorting (FACS) analysis was performed on a BD FACSAria. RBC and nRBCs were separated as described and blocked for 30 min in DMEM/3% FCS (Invitrogen), incubated for 1 hr in either 1:40 PE-conjugated mouse anti-human vitronectin (see IHC) or BD PE-conjugated mouse secondary antibody (negative control, not shown), washed twice in blocking buffer and analyzed. Positive cell counts were observed and recorded using BD FACSDiva software.
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